EMEA-002016-PIP03-19-M02

Table of contents

Key facts

Invented name
Piqray
Active substance
Alpelisib
Therapeutic area
Other
Decision number
P/0412/2022
PIP number
EMEA-002016-PIP03-19-M02
Pharmaceutical form(s)
  • Film-coated tablet
  • Granules
Condition(s) / indication(s)
Treatment of PIK3CA related overgrowth spectrum
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Limited

E-mail: paediatric.enquiries@novartis.com
Tel. +41 6132 41111

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating